Comments 4

超级病菌和疫苗

Feb 11, 2016 Jim O'Neill

伦敦——寨卡病毒的爆发，就像此前的埃博拉病毒一样凸显了传染病可能给整个国家带来的健康风险——以及疫苗在打击传染病迅速传播过程中所起的重要作用。事实上，人们已经开始想办法对上述两种病毒展开预防性接种。

但疫苗也在保护我们对抗耐药菌感染这一更为致命也更可预测的治疗中发挥了至关重要的作用。

相比寨卡病毒等意外、迅速的疫情爆发，耐药性就像是正在上演的一次慢动作车祸。耐药菌每年造成约700,000 人死亡。如果我们不采取必要的预防措施，到2050年它们将每年夺走约一千万人的生命。

To continue reading, please log in or enter your email address.

To continue reading, please log in or register now. After entering your email, you'll have access to two free articles every month. For unlimited access to Project Syndicate, subscribe now.

Featured

Europe’s New Political Battle Lines

Nov 16, 2018 Zaki Laïdi
The Inconvenient Truth About Saudi Arabia

Nov 20, 2018 Richard N. Haass
The Limits of China’s Charm Offensive

Nov 19, 2018 Minxin Pei
Give Italy’s Government a Chance

Nov 16, 2018 Bill Emmott

new comment has been posted. new comments have been posted.

0 Comments on this paragraph, 4 in all 4 Comments on this article

Robbie Jena Feb 11, 2016

Superbug and CDC...the world is really big with over seven Billion people. Why can not others do serious research on bugs? and find good solutions...
A new reply to this comment has been posted.
Michael Public Feb 11, 2016

The problem with vaccines is they can weaken your general system. They can save you improbable things like Rika and deliver you into the arms of probable things like Guillane-Barre Syndrone, Yuppie Flu or Cancer. Count me out.
A new reply to this comment has been posted.
Peter Belmont Feb 11, 2016

The outrageous pricing behavior of the so-called big-pharma (and maybe also little-pharma) makes me wonder -- can I be alone? -- if the capitalist model is the right model for drug R&D&manufacture&sale.

A lot of the research for new drugs and vaccines is done at universities, funded (I suppose) largely by government. If this is so, how much more of the process could usefully be done by government? The problem of providing inexpensive drugs to poor people (and in poor countries) has been recognized and is opposed by big-pharma, including in the proposed TPP.

Similarly, "capitalism" or "free enterprise" left to itself has done nothing to fight Global Warming/Climate Change adn continues (as I see it) to stand in the way of speedy (or even of not-quite-timely) action.

So perhaps, as far as human health is concerned, we should be seeking another model to replace and supplant "free enterprise" with a m,ecnanism that shows better promise of successfully fighting new, resistant, and "orphan" diseases.

Of course, the present system encourages certain deaths -- from diseases today, from climate later -- which is one way, I suppose, to do something we should be doing, namely, reducing the size of the human population. Maybe complaint is, therefore, misplaced. --sad face--
A new reply to this comment has been posted.
Steve Hurst Feb 11, 2016

With regard to the need for new antibiotics - It will be an entire waste of time unless the abuse or misuse of antibiotics - not least by the agri sector - is curtailed. Exisiting misuse is the game is still in play and delivering new resistant pathogens
A new reply to this comment has been posted.

http://prosyn.org/zdtSOqO/zh;

超级病菌和疫苗

To continue reading, please log in or enter your email address.

Featured

Europe’s New Political Battle Lines

The Inconvenient Truth About Saudi Arabia

The Limits of China’s Charm Offensive

Give Italy’s Government a Chance

New Comment

Email this piece to a friend

Contact us

The Global Talent Race

Global Conflict in a New Age of Extremes

America’s Senseless Iran Sanctions

Looking Past Trump

Measuring, and Managing, More Sustainable Growth

The Inconvenient Truth About Saudi Arabia

The Bleak Fate of the Amazon

Saving South Korea’s Economy

Cookies and Privacy

Log in/Register